Search | eNauka

Research outputs

Histology and molecular characteristics of pregnancy associated breast cancer [2015]

Tomasevic, Z.; Milovanović, Zorka ; Tomasevic, Z.M.; Bozovic, Spasojevic I.; Milosevic, S.; Zdrale, Z.; Andjelic, Dekic N.; Kovac, Z.

EPROPA: The European program for routine testing of patients with advanced lung cancer [2021]

Passiglia, F; ...; Secen, Nevena M; ...; (broj, koautora 20)

Survey on the Unmet Needs of Patients Living with mCRC Learnings from an International Study [2019]

Maravic, Zorana; Rawicka, Iga; Lemmens, Liesbeth; Bokros, J; Gonzalez, de Pedro C; Stanisic-Trenevski, Jadranka; Mendez, Otero M; Rial, O; Ferro, T

A pilot study of combined biomarker-based treatment strategies in patients with recurrent/metastatic squamous cell carcinoma of the cervix: RAIDS molecular targets trial for cervical cancer [2020]

Roufai, Bello D; Sadozye, A; Glasspool, RM; Limaye, S; Mandic, Aljosa D ; Popovic, Marina; Ottevanger, N; Roxburgh, P; Lecuru, F; Cherif, L Larbi;

Kamal, Maud; Le, Tourneau C; Rouzier, Roman; Scholl, Suzy M;

ICES (International Carboplatin Emesis Survey) for the evaluation of the emetogenicity of carboplatin-based chemotherapy - with a focus on nausea. MASCC Antiemetic Study Group survey [2020]

Smit, Teresa; Chan, A; Chasen, Martin Robert; Bhargava, Ravi; Bosnjak, Snezana M; Zilic, Ana; Chia, JT; Jabbar, Adnan Abdul; Yaxiong, Z; De, Necker Margreet;

Mhazo, Tina V; Heyman, Liezl; Rapoport, BL;

HERIZON overall survival results: A study of IMU-131, a HER2 targeting peptide vaccine, plus standard of care chemotherapy in patients with HER2 overexpressing metastatic or advanced gastric/GEJ cancer [2022]

Maglakelidze, Marina; Ryspayeva, D; Andric, Zoran G ; Petrovic, Zeljko M; Bulat, IV; Nikolic, Ivan V ; Chawla, T; Nagarkar, R; Wiedermann, Ursula; Blumenstein, BA;

Chong, LMO; Ede, NJ; Nixon, B; Good, AJ;

POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic nonesmall cell lung cancer (mNSCLC) [2024]

Lu, S; Vynnychenko, O; Kulyaba, Y; Kuchava, V; Ibrahim, A; Moiseenko, FV; Arslan, C; Nguyen, DT; Zhang, M; Petrovic, MD;

Cicin, I; Bibichadze, K; Cil, T; Cornfeld, M; Tian, C; Munteanu, M; Sette, CVDM; Bondarenko, I;

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2010]

Eckel, F; Brunner, T; Jelic, Svetislav B

Phase IV study of afatinib as second-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring common epidermal growth factor receptor (EGFR) mutations (Del19 and/or L858R) [2015]

Thongprasert, Sumitra; ...; Jovanovic, D; ...; Petrovic, M; ...; Radosavljevic, Davorin Z; Perin, Branislav M; ...; (broj, koautora 19)

Molecular profiles as a function of treatment response/progression free survival in a prospective cervical cancer study (RAIDs) [2018]

Scholl, Suzy M; De, Koning Leanne; Popovic, Marina; Anne, DLR; Floquet, A; Berns, Els; Kenter, Gemma; Kereszt, A; Girard, E; Von, der Leyen H;

Dureau, S; Fourchotte, V; Rouzier, Roman; Kamal, Maud; Consortium, R;